6-145627577-C-T

Variant summary

Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PS3PM2PM5PP3_StrongPP5_Very_Strong

The NM_005670.4(EPM2A):​c.835G>A​(p.Gly279Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,461,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV004515349: Experimental studies have shown that this missense change affects EPM2A function (PMID:12019207, 14532330)." and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G279C) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

EPM2A
NM_005670.4 missense

Scores

6
9
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 7.57

Publications

14 publications found
Variant links:
Genes affected
EPM2A (HGNC:3413): (EPM2A glucan phosphatase, laforin) This gene encodes a dual-specificity phosphatase and may be involved in the regulation of glycogen metabolism. The protein acts on complex carbohydrates to prevent glycogen hyperphosphorylation, thus avoiding the formation of insoluble aggregates. Loss-of-function mutations in this gene have been associated with Lafora disease, a rare, adult-onset recessive neurodegenerative disease, which results in myoclonus epilepsy and usually results in death several years after the onset of symptoms. The disease is characterized by the accumulation of insoluble particles called Lafora bodies, which are derived from glycogen. [provided by RefSeq, Jan 2018]
EPM2A Gene-Disease associations (from GenCC):
  • Lafora disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 20 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV004515349: Experimental studies have shown that this missense change affects EPM2A function (PMID: 12019207, 14532330).; SCV005908013: "In vitro functional studies provide some evidence that the p.Gly279Ser variant may impact protein function." PMID:12019207, PMID:14532330, PMID:17337485, PMID:18029386, PMID:22124153, PMID:34755096
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr6-145627577-C-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 834981.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.971
PP5
Variant 6-145627577-C-T is Pathogenic according to our data. Variant chr6-145627577-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 3099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005670.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPM2A
NM_005670.4
MANE Select
c.835G>Ap.Gly279Ser
missense
Exon 4 of 4NP_005661.1O95278-1
EPM2A
NM_001018041.2
c.835G>Ap.Gly279Ser
missense
Exon 4 of 5NP_001018051.1O95278-2
EPM2A
NM_001360057.2
c.593G>Ap.Arg198Gln
missense
Exon 3 of 3NP_001346986.1O95278-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPM2A
ENST00000367519.9
TSL:1 MANE Select
c.835G>Ap.Gly279Ser
missense
Exon 4 of 4ENSP00000356489.3O95278-1
EPM2A
ENST00000435470.2
TSL:1
c.835G>Ap.Gly279Ser
missense
Exon 4 of 5ENSP00000405913.2O95278-2
EPM2A
ENST00000638262.1
TSL:1
c.593G>Ap.Arg198Gln
missense
Exon 3 of 3ENSP00000492876.1O95278-5

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000120
AC:
3
AN:
249864
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000267
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000150
AC:
22
AN:
1461878
Hom.:
0
Cov.:
32
AF XY:
0.0000179
AC XY:
13
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53404
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000171
AC:
19
AN:
1112012
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000144
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Lafora disease (1)
1
-
-
Myoclonic epilepsy of Lafora 1 (1)
1
-
-
not provided (1)
1
-
-
Progressive myoclonic epilepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.19
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.63
D
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.94
D
M_CAP
Benign
0.053
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Benign
-0.50
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
7.6
PrimateAI
Uncertain
0.66
T
PROVEAN
Uncertain
-2.5
D
REVEL
Uncertain
0.52
Sift
Benign
0.12
T
Sift4G
Uncertain
0.051
T
Polyphen
1.0
D
Vest4
0.80
MutPred
0.91
Gain of MoRF binding (P = 0.0974)
MVP
0.91
MPC
0.87
ClinPred
0.92
D
GERP RS
5.7
gMVP
0.78
Mutation Taster
=5/95
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137852917; hg19: chr6-145948713; COSMIC: COSV100837401; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.